Waleed H. Hassanein - 10 Mar 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: President & CEO, Director
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 10 Mar 2023
Net transactions value: +$426,694
Form type: 4
Filing time: 14 Mar 2023, 17:01:05 UTC
Previous filing: 02 Mar 2023
Next filing: 04 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Options Exercise	$426,694	+193,074	+51%	$2.21^*	574,191	10 Mar 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-193,074	-100%	$0.000000	1	10 Mar 2023	Common Stock	193,074	$2.21	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the reporting person's cash exercise of a stock option.
F2	Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F3	The option is fully vested.